RaySearch Laboratories AB has received an order for its RayStation® treatment
planning system from the Lucien Neuwirth Institute of Cancerology (ICLN –
Institut de Cancérologie Lucien Neuwirth) in Saint Priest en Jarez, France.
ICLN is a public hospital specialized in cancer treatment and is part of the
Saint Etienne University Campus. The institute offers state-of-the-art cancer
treatments using chemotherapy and advanced radiation therapy and treats 1,900
patients annually.

The institute will primarily use RayStation® as a complement to the existing
treatment planning system to perform advanced techniques such as adaptive
radiation therapy or planning of IMRT treatments using multi-criteria
optimization.

Mustapha Khodri, Head of the Physics department at ICLN comments: “We are always
seeking to improve our treatments and are very interested in new treatment
techniques. RayStation® offers a wide range of advanced and unique tools with
significant potential to improve the treatment quality and make the workflow
more efficient in the radiotherapy department. We are eager to start operating
the system for clinical use”.

Professor Nicolas Magné, Head of ICLN’s Department of Radiotherapy and Director
of Research and Innovation, says: “Being the first in France to have RayStation®
is a real opportunity to develop our research programs. We aim to produce
results that can be applied immediately in our daily clinical practice and are
looking forward to work together with RaySearch to ensure that our patients get
the very best treatments”.

“We are expanding our European operations and we are very happy to present our
first customer in France. ICLN is one of the best research centers in France.
They are at the forefront of the development of new treatment techniques so we
are thrilled that they selected RayStation® as their tool for advanced treatment
planning applications,” says Johan Löf, CEO of RaySearch Laboratories AB.

About RayStation®
RayStation® integrates all RaySearch’s advanced treatment planning solutions
into a flexible treatment planning system. It combines unique features such as
multi-criteria optimization tools with full support for 4D adaptive radiation
therapy. It also includes functionality such as RaySearch’s market-leading
algorithms for IMRT and VMAT optimization and highly accurate dose engines for
both photon and proton therapy. The system is built on the latest software
architecture and has a graphical user interface offering state-of-the-art
usability.

About RaySearch
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch’s
products are mainly sold through license agreements with leading partners such
as Philips, Nucletron, IBA Dosimetry, Varian and Accuray. To date, 15 products
have been launched through partners and RaySearch’s software is used at over
2,000 clinics in more than 30 countries. In addition, RaySearch offers the
proprietary treatment planning system RayStation® directly to clinics. RaySearch
was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and
the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.

For more information about RaySearch, visit www.raysearchlabs.com

For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com